Today /May 20, 2024/, the first batch of children’s cancer drugs supplied within the framework of the “The Global Platform for Access to Childhood Cancer Medicines” 2023-2027 project was delivered to Mongolia. “The Global Platform for Access to Childhood Cancer Medicines” is a joint effort by St. Jude and WHO to end disparities in access to safe and effective medicines to treat children with cancer.

The first batch includes 6 countries from each region of WHO and more than 30 types of drugs for the treatment of childhood cancer was delivered free.

In Mongolia, 100-120 children are diagnosed with cancer annually. 46.7% of children with brain cancer and 70% of children with leukemia live five or more years after their initial diagnosis, which is lower than global averageness. Also, about 30% of the children in treatment drop out without completing the treatment due to drug side effects and other reasons. It is low indicator too. In 2022, 143 new cases of childhood cancer were registered in Mongolia, 53.1% of which were male and 46.9% female.

3000 new cases of childhood cancer are registered in the world every year. Of these, 71.6% occur between the ages of 0-14 and 28.4% occur between the ages of 15-19.